Published in J Natl Cancer Inst on May 01, 1957
Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc Natl Acad Sci U S A (1975) 7.27
Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts. Proc Natl Acad Sci U S A (1976) 3.12
The histogenesis of basement membranes. J Exp Med (1963) 2.38
Pariental yolk sac carcinoma: clue to the histogenesis of Riechert's membrane of the mouse embryo. Am J Pathol (1962) 1.89
From teratocarcinomas to embryonic stem cells. Philos Trans R Soc Lond B Biol Sci (2002) 1.56
Tumorigenicity of pluripotent stem cells: biological insights from molecular imaging. J R Soc Interface (2010) 1.16
Regulation of male germ cell cycle arrest and differentiation by DND1 is modulated by genetic background. Development (2010) 1.08
Sin3a is required by sertoli cells to establish a niche for undifferentiated spermatogonia, germ cell tumors, and spermatid elongation. Stem Cells (2010) 1.06
An experimental mouse testicular teratoma as a model for neuroepithelial neoplasia and differentiation. I. Light microscopic and tissue and organ culture observations. Am J Pathol (1975) 1.05
Deletion of eIF2beta suppresses testicular cancer incidence and causes recessive lethality in agouti-yellow mice. Hum Mol Genet (2009) 1.01
A self-renewal program controls the expansion of genetically unstable cancer stem cells in pluripotent stem cell-derived tumors. Stem Cells (2009) 0.98
A male germ cell tumor-susceptibility-determining locus, pgct1, identified on murine chromosome 13. Proc Natl Acad Sci U S A (2000) 0.97
Germ cell pluripotency, premature differentiation and susceptibility to testicular teratomas in mice. Development (2012) 0.96
Transgenerational epigenetic effects of the Apobec1 cytidine deaminase deficiency on testicular germ cell tumor susceptibility and embryonic viability. Proc Natl Acad Sci U S A (2012) 0.93
Testicular germ cell tumor susceptibility genes from the consomic 129.MOLF-Chr19 mouse strain. Mamm Genome (2007) 0.92
Enhancers and suppressors of testicular cancer susceptibility in single- and double-mutant mice. Genetics (2004) 0.88
Misexpression of cyclin D1 in embryonic germ cells promotes testicular teratoma initiation. Cell Cycle (2016) 0.86
The role of dead-end in germ-cell tumor development. Ann N Y Acad Sci (2007) 0.86
Genetic factors on mouse chromosome 18 affecting susceptibility to testicular germ cell tumors and permissiveness to embryonic stem cell derivation. Cancer Res (2009) 0.85
What leads from dead-end? Cell Mol Life Sci (2007) 0.84
The role of the mouse y chromosome on susceptibility to testicular germ cell tumors. Cancer Res (2009) 0.80
A big catch for germ cell tumour research. PLoS Genet (2013) 0.79
Spontaneous metastasis in mouse models of testicular germ-cell tumours. Int J Androl (2011) 0.77
Parent-of-origin effects of A1CF and AGO2 on testicular germ-cell tumors, testicular abnormalities, and fertilization bias. Proc Natl Acad Sci U S A (2016) 0.77
Contrasting effects of Deadend1 (Dnd1) gain and loss of function mutations on allelic inheritance, testicular cancer, and intestinal polyposis. BMC Genet (2013) 0.77
Tumor loci and their interactions on mouse chromosome 19 that contribute to testicular germ cell tumors. BMC Genet (2014) 0.76
Germ cell tumors: Insights from the Drosophila ovary and the mouse testis. Mol Reprod Dev (2017) 0.75
Expression of insulin-like growth factor II (IGF)-II) and H19 in murine teratocarcinomas derived from embryonic stem (ES) cells. J Anat (1996) 0.75
Development of a testicular tumour during cisclomiphene therapy. Can Med Assoc J (1973) 0.75
Identification of genomic locus responsible for experimentally induced testicular teratoma 1 (ett1) on mouse Chr 18. Mamm Genome (2014) 0.75
Studies on transplantable testicular teratomas of strain 129 mice. J Natl Cancer Inst (1958) 2.01
Developmental anomalies in mice resulting from action of the gene, disorganization, a semi-dominant lethal. Pediatrics (1959) 1.93
Histocompatibility genes of mice. III. H-1 and H-4, two histocompatibility loci in the first linkage group. Immunology (1961) 1.75
Testicular teratomas in fetal mice. J Natl Cancer Inst (1962) 1.48
The inheritance and expression of disorganization, an unusual mutation in the mouse. J Exp Zool (1958) 1.47
Embryology of testicular teratomas in strain 129 mice. J Natl Cancer Inst (1959) 1.34
EXPERIMENTAL PRODUCTION OF TESTICULAR TERATOMAS IN MICE. Proc Natl Acad Sci U S A (1964) 1.24
Embryonic potency of embryoid bodies derived from a transplantable testicular teratoma of the mouse. Dev Biol (1960) 1.13
Evidence on inheritance of muscular dystrophy in an inbred strain of mice using ovarian transplantation. Proc Soc Exp Biol Med (1957) 0.99
KARYOTYPE AND SEX OF PRIMARY TESTICULAR TERATOMAS IN MICE. J Natl Cancer Inst (1964) 0.96
Tests of alternative methods for demonstrating the histocompatibility-1 isoantigen in mice. Transplant Bull (1958) 0.94
Accessory adrenal cortical nodules in the mouse. Anat Rec (1958) 0.88
A modification of Robertson's technique of homoiotopic ovarian transplantation in mice. Transplant Bull (1957) 0.82
The biology of teratomas including evidence indicating their origin form primordial germ cells. Annee Biol (1963) 0.82
Comparative virulence of the mammary tumor agent from different sources: qualitative and quantitative differences. J Natl Cancer Inst (1963) 0.79
Mammary tumors and mammary-gland development in virgin mice of strains C3H, RIII, and their F1 hybrids. J Natl Cancer Inst (1959) 0.79
Comparison of the virulence of the mammary-tumor agent from four strains of mice. J Natl Cancer Inst (1959) 0.77
The development of rib fusions, a mutation in the house mouse. Am J Anat (1960) 0.76
Induced ovarian and adrenal tumors. J Natl Cancer Inst (1954) 0.75
Studies on the mouse mammary tumor agent; the agent in blood and other tissues in relation to the physiologic or endocrine state of the donor. Cancer Res (1949) 0.75
Studies on the mouse mammary tumor agent; survival and propagation of the agent in transplanted tumors and in hosts that grew these tumors in their tissues. Cancer Res (1949) 0.75
Mammary tumors in mice of strains C3H and DBA/1 and their F1 hybrids. Cancer Res (1960) 0.75
Studies on the mouse mammary tumor agent; the neutralization of the agent by placenta. Cancer Res (1949) 0.75